Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Dynatronics Corp (DYNT) delivers innovative medical solutions through advanced rehabilitation equipment and therapeutic devices. This news hub provides investors and healthcare professionals with essential updates directly from the company, ensuring access to verified information about product developments and corporate milestones.
Track official announcements including new product releases, regulatory updates, and strategic partnerships. Our curated feed eliminates the need to monitor multiple sources, offering a centralized repository for earnings reports, leadership changes, and clinical trial progress related to DYNT's medical devices.
Discover updates spanning three key areas: product innovation in physical therapy equipment, distribution network expansions, and clinical support initiatives. Each update is vetted for relevance to investors assessing market position and medical professionals evaluating equipment solutions.
Bookmark this page for streamlined access to Dynatronics' latest developments. Combine regular checks with our news alerts to maintain current awareness of this medical device innovator's progress in rehabilitation technology and patient care solutions.
Dynatronics Corporation (NASDAQ:DYNT) reported its Q2 fiscal year 2023 results, showcasing total net sales of $10.9 million and a gross profit margin increase to 28.1% from 19.8% a year prior. Net loss improved to $0.8 million, down from $1.4 million, and current liabilities reduced by $1.0 million. The company reaffirmed its net sales guidance for fiscal year '23 at $45 million to $48 million, projecting a 5% improvement from the previous year. However, it deferred gross margin guidance due to inflationary pressures and other economic challenges.
Dynatronics Corporation (NASDAQ:DYNT) announced a 1-for-5 reverse stock split effective February 1, 2023, at 5:00 p.m. (ET) to comply with NASDAQ's minimum bid price requirement. As a result, outstanding shares will reduce from approximately 19.6 million to 3.9 million. The common stock will trade on a split-adjusted basis starting February 2, 2023. The reverse stock split will not affect the Series A and B preferred stock, though their conversion ratios will change. The company seeks to maintain compliance with NASDAQ's listing requirements, but no guarantees can be made regarding future compliance.
Dynatronics Corporation (NASDAQ:DYNT) announced its second-quarter financial results for fiscal year 2023, scheduled for release on February 9, 2023, before market open. Following the results, a conference call will take place at 8:00 AM ET, featuring management remarks, a slide presentation, and a Q&A session. Interested participants can access the call by dialing specific numbers provided in the release, and a replay will be available until February 16, 2023. The company manufactures products for athletic training, physical therapy, and rehabilitation, emphasizing its commitment to high-quality restorative solutions.
Dynatronics Corporation (NASDAQ:DYNT) reported its Q1 fiscal year 2023 results, revealing net sales of $12.1 million and a gross profit margin increase to 30.2% from 23.4% in Q4 FY22. The net loss improved to $0.5 million from $1.6 million. The company maintains a debt-free status for the 9th consecutive quarter. Guidance for FY23 net sales is set at $45 million to $48 million, a 5% increase from FY22. However, due to inflation, gross margin guidance is deferred as the company anticipates continued volatility from economic challenges.
FAQ
What is the current stock price of Dynatronics (DYNT)?
What is the market cap of Dynatronics (DYNT)?
